微小RNA15A与16-1激活介导免疫调节性B细胞向结直肠肿瘤趋化的信号通路
研究在结直肠肿瘤小鼠模型及90例患者组织芯片中探讨MIR15A/MIR16-1对IgA+ B细胞介导免疫抑制的调控。敲除小鼠肿瘤更大且B细胞更多,过表达可减慢肿瘤生长;人组织中MIR15A/16-1高且IgA+ B细胞少与生存期延长相关。
要点
- MIR15A/MIR16-1缺失小鼠结直肠肿瘤更大且IgA+ B细胞浸润更多。
- MIR15A/MIR16-1在人结直肠肿瘤中与IgA+ B细胞数量呈负相关。
- MIR15A/MIR16-1高且IgA+ B细胞少与患者生存期延长相关。
核心结论
- MIR15A和MIR16-1水平升高可减少结直肠肿瘤组织中的IgA+ B细胞并与患者生存期延长相关;缺失时小鼠结肠肿瘤生长更快且IgA+ B细胞增多;MIR15A和MIR16-1似乎激活B细胞介导免疫抑制所需的信号通路。
研究设计与样本
- 研究使用MIR15A/MIR16-1基因簇敲除小鼠与对照C57BL/B6小鼠,给予偶氮甲烷联合葡聚糖硫酸钠(AD)诱导结直肠肿瘤。
- 小鼠接受抗CD20清除B细胞或注射agomir提高MIR15A和MIR16-1;用羧基荧光素琥珀酰亚胺酯分析检测CD8+ T细胞增殖。
- 收集小鼠结肠组织行流式细胞术、微小RNA测序和细胞因子检测;分离肠上皮细胞(IEC)转染miRNA模拟物以鉴定靶点。
- 分析2006年7月至2008年4月中国上海90例手术切除患者结直肠癌组织芯片的miRNA表达模式并量化B细胞,与临床结局比较。
主要发现
- AD处理后敲除小鼠发生的肿瘤比对照小鼠更大且含更多B细胞;肿瘤中多数B细胞为IgA+。
- IgA+ B细胞高表达免疫调节分子(程序性死亡配体1、白细胞介素10、转化生长因子β),并抑制CD8+ T细胞增殖与活化。
- 小鼠结肠肿瘤中MIR15A和MIR16-1水平低于非肿瘤结肠组织;IEC与IL17A孵育降低MIR15A和MIR16-1表达。
- IEC转基因表达MIR15A和MIR16-1通过减少I-kappaB激酶表达降低NF-κB和STAT1活化,减少趋化因子(C-X-C基序)配体9和10产生并降低IgA+ B细胞趋化。
- 注射AD和agomir的小鼠肿瘤生长比未给agomir的小鼠更慢且含更少IgA+ B细胞;人结直肠肿瘤组织中MIR15A和MIR16-1水平与IgA+ B细胞数量呈负相关,MIR15A和MIR16-1高且IgA+ B细胞少与患者生存时间更长相关。
关键数值与推荐
- 在90例手术切除患者结直肠癌组织芯片中,MIR15A和MIR16-1水平与IgA+ B细胞数量呈负相关。
- 人结直肠肿瘤组织中MIR15A和MIR16-1高且IgA+ B细胞少与患者生存时间更长相关。
- AD处理后敲除小鼠肿瘤比对照小鼠更大且含更多B细胞。
- 注射AD和agomir的小鼠肿瘤比未给agomir的小鼠生长更慢且含更少IgA+ B细胞。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: B cells infiltrate tumors, but little is known about how they affect tumor growth and progression. microRNA15A (MIR15A or miRNA15A) and microRNA16-1 (MIR16-1 or miRNA16-1) regulate cell proliferation, apoptosis, and drug resistance. We investigated their involvement in B-cell-mediated immune suppression by colorectal tumors. METHODS: Mice with disruptions of the gene cluster that encodes MIR15A and MIR16-1 (knockout mice), and control (C57BL/B6) mice were given azoxymethane with dextran sodium sulfate (AD) to induce formation of colorectal tumors. Mice were given anti-CD20 to delete B cells, or injections of agomir to increase MIR15A and MIR16-1. Proliferation of CD8+T cells was measured by carboxyfluorescein-succinimidyl-ester analysis. Colon tissues were collected from mice and analyzed by flow cytometry, microRNA (miRNA) sequencing, and for cytokine production. Intestinal epithelial cells (IECs) were isolated and transfected with miRNA mimics, to identify their targets. We analyzed miRNA expression patterns and quantified B cells in colorectal cancer tissue microarrays derived from 90 patients who underwent surgical resection, from July 2006 through April 2008, in Shanghai, China; expression data were compared with clinical outcomes. RESULTS: Tumors that developed in knockout mice following administration of AD were larger and contained greater numbers of B cells than tumors that grew in control mice. Most of the B cells in the tumors were positive for immunoglobulin A (IgA+). IgA+ B cells expressed high levels of immune regulatory molecules (programmed death ligand 1, interleukin 10, and transforming growth factor beta), and repressed the proliferation and activation of CD8+ T cells. Levels of MIR15A and MIR16-1 were reduced in colon tumors from mice, compared with nontumor colon tissue. Incubation of IECs with IL17A reduced expression of MIR15A and MIR16-1. Transgenic expression of MIR15A and MIR16-1 in IECs decreased activation of NF-κB and STAT1 by reducing expression of I-kappaB kinases; this resulted in reduced production of chemokine (C-X-C motif) ligands 9 and 10 and decreased chemotaxis of IgA+ B cells. Tumors in mice injected with AD and agomir grew more slowly than tumors in mice not given in agomir and contained fewer IgA+ B cells. We found a negative correlation between levels of MIR15A and MIR16-1 and numbers of IgA+B cells in human colorectal tumor tissues; high levels of MIR15A and MIR16-1 and low numbers of IgA+B cells were associated with longer survival times of patients. CONCLUSIONS: We found increased levels of MIR15A and MIR16-1 to reduce numbers of IgA+ B cells in colorectal tumor tissues and correlate with increased survival time of patients. In mice that lack MIR15A and MIR16-1, colon tumors grow more rapidly and contain increased numbers of IgA+ B cells. MIR15A and MIR16-1 appear to activate signaling pathways required for B-cell-mediated immune suppression.
引用
- Liu R, Lu Z, Gu J, et al. MicroRNAs 15A and 16-1 Activate Signaling Pathways That Mediate Chemotaxis of Immune Regulatory B cells to Colorectal Tumors. Gastroenterology. 2017. PMID: 29031499. doi:10.1053/j.gastro.2017.09.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。